International Conference On Microneedles News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from International conference on microneedles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In International Conference On Microneedles Today - Breaking & Trending Today

Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children


– Phase 1/2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of Micron s Microneedle-Based Measles-Rubella Vaccine –
ATLANTA, July 13, 2021 /PRNewswire/ - Micron Biomedical, Inc. ( Micron or the Company ), a leader in dissolving, microneedle-based vaccine and drug delivery, today announced that it has initiated a Phase 1/2 clinical trial of its microneedle-based measles-rubella ( MR ) vaccine.
The trial will assess the safety, tolerability and immunogenicity of an MR vaccine delivered using Micron s technology, compared with delivery via standard subcutaneous injection, in adults and children. The Company-sponsored Phase 1/2 trial will be conducted at the Medical Research Council Unit The Gambia ( MRCG ) under the leadership of Ed Clarke, MB ChB PhD, Head of Infant Immunology at the London School of Hygiene and Tropical Medicine ( LSHTM ) in The Gambia. ....

United States , Devin Mcallister , Paul Rota , Mark Prausnitz , Ted Clarke , Sebastien Henry , Centers For Disease , Research Council Unit , World Health Organization , Viral Vaccine Preventable Diseases Branch , Melinda Gates Foundation , London School Of Hygiene , Micron Biomedical Inc , International Conference On Microneedles , Georgia Research Alliance , Microneedle Based Measles Rubella Vaccine , Company Sponsored Phase , Medical Research Council Unit The Gambia , Infant Immunology , London School , Tropical Medicine , Vice President , Saharan Africa , Disease Control , Vaccine Preventable Diseases , Melinda Gates ,